Studies long-lasting symptoms in adults after COVID-19 in Brazil
Looks at who gets lasting symptoms after COVID-19 in adults in Brazil.
Plain-language title generated from the registry record
Registry title: Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
Key facts
- Where
- Cachoeirinha, BrazilSee the site
Where in Brazil
- Inova MedicalCachoeirinha, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Inova Medical
- Trial code
- NCT05822193
- Record updated
- 19 February 2025
- Original description
This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.Read full original descriptionShow less
Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.
Inclusion: Age ≥ 18 years; Brazilian resident; Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment.
Exclusion: Communication difficulty (aphasia, important hearing loss, non-portuguese speaker, severe dementia); No availability to participate in remote research appointments; Refuse to provide informed consent.